Diagnostic Role of Opsonic Activity in Acinetobacter baumannii Ventilator-Associated Pneumonia

Asiye Karakullukçu1, Mustafa Akker2, Mert Ahmet Kuşkucu3

  • 1Istanbul Health and Technology University, Faculty of Medicine, Department of Medical Microbiology, Istanbul 34275, Turkey.

Insights

Opsonic activity against Acinetobacter baumannii shows promise as a diagnostic tool for Ventilator-Associated Pneumonia (VAP). This assay demonstrated high sensitivity and specificity, outperforming traditional clinical scores.

Area of Science:

  • Clinical Microbiology
  • Infectious Diseases
  • Diagnostic Immunology

Background:

  • Ventilator-Associated Pneumonia (VAP) poses a significant challenge in intensive care settings.
  • Accurate and timely diagnosis of VAP is crucial for effective patient management.
  • Current diagnostic methods, including the Clinical Pulmonary Infection Score (CPIS), have limitations in differentiating VAP from colonization.

Purpose of the Study:

  • To evaluate the diagnostic utility of opsonic activity against Acinetobacter baumannii in VAP.
  • To compare the performance of opsonic activity assay with the CPIS and microbiological findings.

Main Methods:

  • Opsonic activity assay was performed on patient samples.
  • Sensitivity, specificity, and Receiver Operating Characteristic (ROC) analysis were calculated.
  • Comparison with CPIS and microbiological data was conducted in 50 VAP patients and controls.

Main Results:

  • Opsonic activity demonstrated high sensitivity (95%) and specificity (91.7%) in distinguishing A. baumannii culture positives.
  • The assay showed 95% sensitivity and 78.7% specificity in differentiating VAP/blood culture positives from colonized/negative groups (ROC area 0.915).
  • CPIS alone showed an indeterminate threshold (ROC area 0.553) for VAP and colonization, with poor correlation to microbiological and clinical evaluations.

Conclusions:

  • Opsonic activity against A. baumannii is a potential biomarker for VAP diagnosis.
  • The opsonic assay shows superior diagnostic performance compared to CPIS.
  • Further large-scale validation studies are warranted to confirm its clinical utility.